CAR Detection & Characterization

From CAR expression to cell state: four categories of detection tools

CAR detection must cover expression level, cell subset, functional state and soluble markers.

Detection needs for transduced samples fall into four categories: expression level, subset assignment, functional state (activation and exhaustion) and soluble markers (cytokines and shed CAR in supernatant). Sample handling and interpretation differ between categories, and a single marker cannot replace the others.

 
CAR-X™ Solution  ›  This page

WHAT | What we offer

01 | CAR Expression Detection

Flow cytometric detection of surface CAR depends on which epitope the antibody recognizes. CAR-X provides four recognition routes: G4S Linker, Whitlow (218) Linker, VHH and FMC63 anti-idiotype. The first three recognize linker or framework regions and are independent of the scFv sequence; the fourth recognizes the FMC63 idiotype and is valid only for FMC63-derived CARs.

Conjugates: PE / FITC / APC / Biotin

Cat NoProduct NameSizeDetails
GMLS-Tag003-Ab01Anti-G4S Linker monoclonal antibody25 T / 100 T / 500 TDetails
GMLS-Tag006-Ab01Anti-Whitlow (218) Linker monoclonal antibody25 T / 100 T / 500 TDetails
GMLS-Tag002-Ab01Anti-VHH monoclonal antibody25 T / 100 T / 500 TDetails
GTU-ADA-FMC63-Ab01~06Anti-FMC63 monoclonal antibody(anti-idiotype)25 T / 100 T / 500 TDetails
GMLS-Tag007-Ab01Anti-G3S monoclonal antibody25 T / 100 T / 500 TDetails

Three typical detection scenarios

Scenario 1 | Basic CAR-T phenotype panel: CD3 / CD4 / CD8 / CD56 combined with a CAR detection antibody, read out as positivity and CD4/CD8 ratio.

Scenario 2 | Exhaustion and activation assessment: PD-1 / TIM-3 / LAG-3 / TIGIT added to the basic panel together with CD25 / CD69 / CD137, to assess functional retention after expansion.

Scenario 3 | Soluble CAR monitoring: sequential sampling of supernatant for soluble CAR, to assess the stability of CAR expression during culture.

WHY | Why multi-dimensional detection

Research questionDetection requirementGeneMedi support
Is CAR successfully expressed?Recognize a structure-related region of the CARAnti-G4S / Anti-Whitlow (218) / Anti-VHH / Anti-FMC63
Which detection tool fits a given construct?Select antibody according to CAR structure and recognition regionDetection antibodies for four recognition routes
Which immune subsets make up the engineered population?Analyse T/NK and other subsetsFlow cytometry antibodies for CD3 / CD4 / CD8 / CD56
Do cells show a specific activation or exhaustion phenotype?Detect activation, exhaustion and memory markersCD25 / CD69 / PD-1 / TIM-3 / CCR7
How are cell-associated cytokines analysed?Measure cytokine levelsIL-2 / IFN-γ / IL-6 / TNF-α ELISA
How is the CAR target antigen detected?Detect target antigen expressionAnti-TAA flow cytometry antibodies

CAR expression detection, cell phenotyping and soluble CAR quantification address expression, state and release respectively; they are complementary and not interchangeable.

HOW | Three steps

01

CAR Expression Detection

confirm the linker type of the construct before selecting an antibody; include an FMO control in flow cytometry.

02

Immune Cell Phenotyping

stain lineage and state markers on the same sample; check fluorochrome combination and compensation.

03

Target & Cytokine Analysis

target antigen detection (Anti-TAA) and cytokine quantification (ELISA) as required by the study.

FAQ

1What is the essential difference between anti-linker and anti-idiotype?

The former recognizes a linker sequence on the construct and remains valid after the scFv is changed; the latter recognizes the idiotype of a specific scFv and covers one CAR only.

2What if the construct is not characterized?

First check whether the sequence contains G4S / Whitlow 218 / VHH; if none are present, use the anti-idiotype route or a custom antibody.

3Can two antibodies be used on the same sample simultaneously?

Yes, provided the epitopes do not overlap and the fluorochromes can be separated.

4Which component does the soluble CAR ELISA measure?

The CAR ectodomain shed into culture supernatant or serum, not cell-surface CAR.

5Must all phenotype targets be measured?

No. Combine markers according to the research question; a basic 4–6 colour panel answers most questions.

6Are Claudin 18.2 and Claudin 18 the same protein?

The CLDN18 gene gives rise to two splice variants: CLDN18.1, expressed mainly in lung epithelium, and CLDN18.2, expressed mainly in gastric mucosa and the target of agents such as zolbetuximab. The Anti-TAA antibody listed here is raised against Claudin 18 (full-length CLDN18) and is intended for general target-expression confirmation; distinguishing CLDN18.1 from CLDN18.2 requires an isoform-specific reagent validated for that purpose.




<